Advertisement

Digestive Diseases and Sciences

, Volume 63, Issue 10, pp 2722–2728 | Cite as

Children with Crohn’s Disease Frequently Consume Select Food Additives

  • Dale Lee
  • C. Kaiulani Swan
  • David Suskind
  • Ghassan Wahbeh
  • Jairam Vanamala
  • Robert N. Baldassano
  • Mary B. Leonard
  • Johanna W. Lampe
Original Article
  • 95 Downloads

Abstract

Objective

Certain food additives may promote the pathogenesis of Crohn’s disease (CD), but thus far the evaluation of food additive exposures in humans has been limited. The objective of this study was to quantify food additive exposures in children with CD.

Methods

In a trial for bone health in CD, children were followed over 24 months with evaluation of disease characteristics, dietary intake, and body composition. At baseline, participants completed three 24-h dietary recalls. Foods were categorized, and the ingredient list for each item was evaluated for the presence of select food additives: polysorbate-80, carboxymethylcellulose, xanthan gum, soy lecithin, titanium dioxide, carrageenan, maltodextrin, and aluminosilicates. The frequency of exposures to these food additives was described for study participants and for food categories.

Results

At study baseline, 138 participants, mean age 14.2 ± 2.8 years, 95% having inactive or mild disease, were enrolled and dietary recalls were collected. A total of 1325 unique foods were recorded. Mean exposures per day for xanthan gum was 0.96 ± 0.72, carrageenan 0.58 ± 0.63, maltodextrin 0.95 ± 0.77, and soy lecithin 0.90 ± 0.74. The other additives had less than 0.1 exposures per day. For the 8 examined food additives, participants were exposed to a mean (SD) of 3.6 ± 2.1 total additives per recall day and a mean (SD) of 2.4 ± 1.0 different additives per day.

Conclusion

Children with CD frequently consume food additives, and the impact on disease course needs further study.

Keywords

Food additives Crohn’s disease Dietary recall Nutrition Methodology 

Notes

Acknowledgments

The authors would like to acknowledge Dr. James D. Lewis for editing the manuscript.

Funding

NIH R01-DK073946 (MBL), K24-DK076808 (MBL), T32-DK007740 (DL), the University of Pennsylvania Clinical and Translational Science Award (UL1-RR-024134 and UL1-TR-000003); P30 CA015704 (Cancer Core Grant funding Nutrition Assessment Shared Resource); and the Clinical Research Scholar’s Program at Seattle Children’s Hospital (DL).

Compliance with ethical standards

Conflict of interest

None.

Supplementary material

10620_2018_5145_MOESM1_ESM.docx (81 kb)
Supplementary material 1 (DOCX 80 kb)

References

  1. 1.
    Lee D, Albenberg L, Compher C, et al. Diet in the Pathogenesis and Treatment of Inflammatory Bowel Diseases. Gastroenterology. 2015;148:1087–1106.CrossRefGoogle Scholar
  2. 2.
    Day AS, Whitten KE, Sidler M, et al. Systematic review: nutritional therapy in paediatric Crohn’s disease. Aliment Pharmacol Ther. 2008;27:293–307.CrossRefGoogle Scholar
  3. 3.
    Obih C, Wahbeh G, Lee D, et al. Specific carbohydrate diet for pediatric inflammatory bowel disease in clinical practice within an academic IBD center. Nutrition. 2016;32:418–425.CrossRefGoogle Scholar
  4. 4.
    Sigall-Boneh R, Pfeffer-Gik T, Segal I, et al. Partial enteral nutrition with a Crohn’s disease exclusion diet is effective for induction of remission in children and young adults with Crohn’s disease. Inflamm Bowel Dis. 2014;20:1353–1360.CrossRefGoogle Scholar
  5. 5.
    Suskind DL, Cohen SA, Brittnacher MJ, et al. Clinical and Fecal Microbial Changes With Diet Therapy in Active Inflammatory Bowel Disease. J Clin Gastroenterol. 2018;52:155–163.PubMedGoogle Scholar
  6. 6.
    Heuschkel RB, Menache CC, Megerian JT, et al. Enteral nutrition and corticosteroids in the treatment of acute Crohn’s disease in children. J Pediatr Gastroenterol Nutr. 2000;31:8–15.CrossRefGoogle Scholar
  7. 7.
    Day AS, Lopez RN. Exclusive enteral nutrition in children with Crohn’s disease. World J Gastroenterol. 2015;21:6809–6816.CrossRefGoogle Scholar
  8. 8.
    Suskind DL, Wahbeh G, Gregory N, et al. Nutritional therapy in pediatric Crohn disease: the specific carbohydrate diet. J Pediatr Gastroenterol Nutr. 2014;58:87–91.CrossRefGoogle Scholar
  9. 9.
    Olendzki BC, Silverstein TD, Persuitte GM, et al. An anti-inflammatory diet as treatment for inflammatory bowel disease: a case series report. Nutr J. 2014;13:5.CrossRefGoogle Scholar
  10. 10.
    Molodecky NA, Soon IS, Rabi DM, et al. Increasing incidence and prevalence of the inflammatory bowel diseases with time, based on systematic review. Gastroenterology. 2012;142:46e42–54e42. quiz e30.CrossRefGoogle Scholar
  11. 11.
    Hou JK, Abraham B, El-Serag H. Dietary intake and risk of developing inflammatory bowel disease: a systematic review of the literature. Am J Gastroenterol. 2011;106:563–573.CrossRefGoogle Scholar
  12. 12.
    Roberts CL, Keita AV, Duncan SH, et al. Translocation of Crohn’s disease Escherichia coli across M-cells: contrasting effects of soluble plant fibres and emulsifiers. Gut. 2010;59:1331–1339.CrossRefGoogle Scholar
  13. 13.
    Butler M, Boyle JJ, Powell JJ, et al. Dietary microparticles implicated in Crohn’s disease can impair macrophage phagocytic activity and act as adjuvants in the presence of bacterial stimuli. Inflamm Res. 2007;56:353–361.CrossRefGoogle Scholar
  14. 14.
    Chassaing B, Koren O, Goodrich JK, et al. Dietary emulsifiers impact the mouse gut microbiota promoting colitis and metabolic syndrome. Nature. 2015;519:92–96.CrossRefGoogle Scholar
  15. 15.
    Tobacman JK. Review of harmful gastrointestinal effects of carrageenan in animal experiments. Environ Health Perspect. 2001;109:983–994.CrossRefGoogle Scholar
  16. 16.
    Swidsinski A, Ung V, Sydora BC, et al. Bacterial overgrowth and inflammation of small intestine after carboxymethylcellulose ingestion in genetically susceptible mice. Inflamm Bowel Dis. 2009;15:359–364.CrossRefGoogle Scholar
  17. 17.
    Nickerson KP, Chanin R, McDonald C. Deregulation of intestinal anti-microbial defense by the dietary additive, maltodextrin. Gut Microbes. 2015;6:78–83.CrossRefGoogle Scholar
  18. 18.
    Kullenberg D, Taylor LA, Schneider M, et al. Health effects of dietary phospholipids. Lipids Health Dis. 2012;11:3.CrossRefGoogle Scholar
  19. 19.
    Willett W. Nutritional epidemiology. New York: Oxford University Press; 1998.CrossRefGoogle Scholar
  20. 20.
    Johnson RK. Dietary intake–how do we measure what people are really eating? Obes Res. 2002;10:63S–68S.CrossRefGoogle Scholar
  21. 21.
    Leonard MB, Shults J, Long J, et al. Effect of Low Magnitude Mechanical Stimuli on Bone Density and Structure in Pediatric Crohn’s Disease: A Randomized Placebo Controlled Trial. J Bone Miner Res. 2016;31:1177–1188.CrossRefGoogle Scholar
  22. 22.
    Posner BM, Borman CL, Morgan JL, et al. The validity of a telephone-administered 24-hour dietary recall methodology. Am J Clin Nutr. 1982;36:546–553.CrossRefGoogle Scholar
  23. 23.
  24. 24.
    Hyams JS, Ferry GD, Mandel FS, et al. Development and validation of a pediatric Crohn’s disease activity index. J Pediatr Gastroenterol Nutr. 1991;12:439–447.PubMedGoogle Scholar
  25. 25.
    Shah ZH, Huffman FG. Current availability and consumption of carrageenan-containing foods. Ecology of Food and Nutrition. 2002;42:357–371.CrossRefGoogle Scholar
  26. 26.
    Gibney MJ. Dietary intake methods for estimating food additive intake. Regul Toxicol Pharmacol. 1999;30:S31–S33.CrossRefGoogle Scholar
  27. 27.
    Connolly A, Hearty A, Nugent A, et al. Pattern of intake of food additives associated with hyperactivity in Irish children and teenagers. Food Addit Contam Part A Chem Anal Control Expo Risk Assess. 2010;27:447–456.CrossRefGoogle Scholar
  28. 28.
    Vin K, Connolly A, McCaffrey T, et al. Estimation of the dietary intake of 13 priority additives in France, Italy, the UK and Ireland as part of the FACET project. Food Addit Contam Part A Chem Anal Control Expo Risk Assess. 2013;30:2050–2080.CrossRefGoogle Scholar
  29. 29.
    McCann D, Barrett A, Cooper A, et al. Food additives and hyperactive behaviour in 3-year-old and 8/9-year-old children in the community: a randomised, double-blinded, placebo-controlled trial. Lancet. 2007;370:1560–1567.CrossRefGoogle Scholar
  30. 30.
    Willett WC, Sampson L, Stampfer MJ, et al. Reproducibility and validity of a semiquantitative food frequency questionnaire. Am J Epidemiol. 1985;122:51–65.CrossRefGoogle Scholar
  31. 31.
    Ma Y, Olendzki BC, Pagoto SL, et al. Number of 24-hour diet recalls needed to estimate energy intake. Ann Epidemiol. 2009;19:553–559.CrossRefGoogle Scholar
  32. 32.
    Rompelberg C, Heringa MB, van Donkersgoed G, et al. Oral intake of added titanium dioxide and its nanofraction from food products, food supplements and toothpaste by the Dutch population. Nanotoxicology. 2016;10:1404–1414.CrossRefGoogle Scholar
  33. 33.
    Scalbert A, Brennan L, Manach C, et al. The food metabolome: a window over dietary exposure. Am J Clin Nutr. 2014;99:1286–1308.CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC, part of Springer Nature 2018

Authors and Affiliations

  1. 1.Seattle Children’s HospitalSeattleUSA
  2. 2.University of WashingtonSeattleUSA
  3. 3.Penn State UniversityUniversity ParkUSA
  4. 4.The Children’s Hospital of PhiladelphiaPhiladelphiaUSA
  5. 5.Stanford UniversityPalo AltoUSA
  6. 6.Division of Public Health SciencesFred Hutchinson Cancer Research CenterSeattleUSA

Personalised recommendations